
Study Highlights UroLiftâ„¢ System’s Advantages Over RezÅ«mâ„¢ in Treating BPH
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLiftâ„¢ System with RezÅ«mâ„¢ Water Vapor Therapy (WVTT) …
Study Highlights UroLiftâ„¢ System’s Advantages Over RezÅ«mâ„¢ in Treating BPH Read More